GSK2556286 is a novel antitubercular drug candidate effective in vivo with the potential to shorten tuberculosis treatment
Eric L. Nuermberger, Maria Santos Martínez-Martínez, Olalla Sanz, Beatriz Urones, Jorge Esquivias, Heena Soni, Rokeya Tasneen, Sandeep Tyagi, Si-Yang Li, Paul J. Converse, Helena I. Boshoff, Gregory T Robertson, Gurdyal S Besra, Katherine A. Abrahams, Anna M Upton, Khisimuzi Mdluli, Gary W Boyle, Sam Turner, Nader Fotouhi, Nicholas C. Cammack, Juan Miguel Siles, Marta Alonso, Jaime Escribano, Joel Lelievre, Esther Pérez-Herrán, Robert H. Bates, Gareth Maher-Ewards, David Barros, Lluís Ballell, Elena Jiménez
bioRxiv 2022.02.04.479214; doi: https://doi.org/10.1101/2022.02.04.479214